Psychostimulants as cognitive enhancers: The prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder

Biological Psychiatry

Volumn 69, Issue 12, 2011, Pages

  Berridge, Craig W ^a   Devilbiss, David M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ADHD; cognition; dopamine; norepinephrine; prefrontal cortex; stimulants

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; ATOMOXETINE; CATECHOLAMINE; DESIPRAMINE; DOPAMINE 1 RECEPTOR; IMIPRAMINE; METHYLPHENIDATE; MONOAMINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PSYCHOSTIMULANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACTION POTENTIAL; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; CARDIOVASCULAR DISEASE; CATECHOLAMINE BRAIN LEVEL; COGNITION; DRUG BINDING; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; LOCUS CERULEUS; LOW DRUG DOSE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; UNSPECIFIED SIDE EFFECT;

ADRENERGIC AGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; HUMANS; MONOAMINE OXIDASE INHIBITORS; NEURONS; PREFRONTAL CORTEX; SYNAPTIC TRANSMISSION;

EID: 79958079437     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.06.023     Document Type: Review

References (132)

1. D.S. Segal Behavioral and neurochemical correlates of repeated d-amphetamine administration Adv Biochem Psychopharmacol 13 1975 247 262
2. G.V. Rebec, and T.R. Bashore Critical issues in assessing the behavioral effects of amphetamine Neurosci Biobehav Rev 8 1984 153 159 (Pubitemid 14118787)
3. J. McGaughy, and M. Sarter Behavioral vigilance in rats: Task validation and effects of age, amphetamine, and benzodiazepine receptor ligands Psychopharmacology (Berl) 117 1995 340 357
4. C.W. Berridge, and T.A. Stalnaker Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex Synapse 46 2002 140 149 (Pubitemid 35155167)
5. A.F.T. Arnsten, and A.G. Dudley Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder Behav Brain Funct 1 2005 2
6. D.M. Devilbiss, and C.W. Berridge Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness Biol Psychiatry 64 2008 626 635
7. C. Bradley The behavior of children receiving benzadrine Am J Psychiatry 94 1937 577 585
8. L.L. Greenhill Clinical effects of stimulant medication in ADHD M.V. Solanto, A.F.T. Arnsten, F.X. Castellanos, Stimulant Drugs and ADHD: Basic and Clinical Neuroscience 2001 Oxford University Press New York 31 71
9. L. Hechtman, H. Abikoff, R.G. Klein, G. Weiss, C. Respitz, and J. Kouri Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment J Am Acad Child Adolesc Psychiatry 43 2004 812 819 (Pubitemid 38808486)
10. R.M. Scheffler, T.T. Brown, B.D. Fulton, S.P. Hinshaw, P. Levine, and S. Stone Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school Pediatrics 123 2009 1273 1279
11. P.H. Wender, F.W. Reimherr, and D.R. Wood Stimulant therapy of "adult hyperactivity" Arch Gen Psychiatry 42 1985 840
12. H. Abikoff, L. Hechtman, R.G. Klein, R. Gallagher, K. Fleiss, and J. Etcovitch Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment J Am Acad Child Adolesc Psychiatry 43 2004 820 829 (Pubitemid 38808487)
13. J.H. Newcorn, C.J. Kratochvil, A.J. Allen, C.D. Casat, D.D. Ruff, R.J. Moore, and D. Michelson Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response Am J Psychiatry 165 2008 721 730 (Pubitemid 351810541)
14. J.L. Rapoport, M.S. Buchsbaum, H. Weingartner, T.P. Zahn, C. Ludlow, and E.J. Mikkelsen Dextroamphetamine Its cognitive and behavioural effects in normal and hyperactive boys and normal men Arch Gen Psychiatry 37 1980 933 943 (Pubitemid 10034569)
15. C.J. Vaidya, G. Austin, G. Kirkorian, H.W. Ridlehuber, J.E. Desmond, G.H. Glover, and J.D.E. Gabrieli Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study Proc Natl Acad Sci U S A 95 1998 14494 14499 (Pubitemid 28549395)
16. M.A. Mehta, A.M. Owen, B.J. Sahakian, N. Mavaddat, J.D. Pickard, and T.W. Robbins Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain J Neurosci 20 2000 RC65
17. M.A. Mehta, B.J. Sahakian, and T.W. Robbins Comparative psycholpharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals M.V. Solanto, A.F.T. Arnsten, F.X. Castellanos, Stimulant Drugs and ADHD: Basic and Clinical Neuroscience 2001 Oxford University Press New York 303 331
18. J.L. Rapoport, and G. Inoff-Germain Responses to methylphenidate in attention-deficit/hyperactivity disorder and normal children: Update 2002 J Atten Disord 6 2002 S57 S60
19. J. Swanson, and N. Volkow Pharmacokinetic and Pharmacodynamic Properties of Methylphenidate in Humans 2001 Oxford University Press New York
20. R. Kuczenski, and D.S. Segal Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine J Neurosci 22 2002 7264 7271
21. C.W. Berridge, D.M. Devilbiss, M.E. Andrzejewski, A.F.T. Arnsten, A.E. Kelley, and B. Schmeichel Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function Biol Psychiatry 60 2006 1111 1120 (Pubitemid 44647216)
22. A. Zdrale, T.B. Meier, C.W. Berridge, and L.C. Populin Effect of methylphenidate on monkey prefrontal cortex-mediated behavior Program No. 388.18, Neuroscience Meeting Planner 2008 Society for Neuroscience Washington, DC 2008
23. M.V. Solanto Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration Behav Brain Res 94 1998 127 152 (Pubitemid 28352470)
24. R.A. Barkley, and J. Biederman Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder J Am Acad Child Adolesc Psychiatry 36 1997 1204 1210 (Pubitemid 27381276)
25. A.F. Arnsten Stimulants: Therapeutic actions in ADHD Neuropsychopharmacology 31 2006 2376 2383 (Pubitemid 44607054)
26. F.X. Castellanos, and R. Tannock Neuroscience of attention-deficit/ hyperactivity disorder: The search for endophenotypes Nat Rev Neurosci 3 2002 617 628 (Pubitemid 135706670)
27. C. Kieling, R.R. Goncalves, R. Tannock, and F.X. Castellanos Neurobiology of attention deficit hyperactivity disorder Child Adolesc Psychiatr Clin N Am 17 2008 285 307 (Pubitemid 351258357)
28. P. Shaw, K. Eckstrand, W. Sharp, J. Blumenthal, J.P. Lerch, and D. Greenstein Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation Proc Natl Acad Sci U S A 104 2007 19649 19654
29. G. Bush, E.M. Valera, and L.J. Seidman Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions Biol Psychiatry 57 2005 1273 1284 (Pubitemid 40798546)
30. J. Setlik, G.R. Bond, and M. Ho Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications Pediatrics 124 2009 875 880
31. S.E. McCabe, J.R. Knight, C.J. Teter, and H. Wechsler Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey Addiction 100 2005 96 106
32. B. Maher Poll results: Look who's doping Nature 452 2008 674 675 (Pubitemid 351521058)
33. R. Kuczenski, and D.S. Segal Regional norepinephrine response to amphetamine using dialysis: Comparison with caudate dopamine Synapse 11 1992 164 169
34. R. Kuczenski, D.S. Segal, A.K. Cho, and W. Melega Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine J Neurosci 15 1995 1308 1317
35. R. Kuczenski, and D.S. Segal Neurochemistry of amphetamine A.K. Cho, D.S. Segal, Amphetamine and Its Analogues: Psychopharmacology, Toxicology and Abuse 1994 Academic Press San Diego 81 113
36. S.M. Florin, R. Kuczenski, and D.S. Segal Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment Brain Res 654 1994 53 62 (Pubitemid 24259401)
37. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine J Neurochem 68 1997 2032 2037 (Pubitemid 27176139)
38. R. Kuczenski, and D.S. Segal Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine J Pharmacol Exp Ther 296 2001 876 883 (Pubitemid 32187360)
39. C. Drouin, M. Page, and B. Waterhouse Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats J Neurophysiol 96 2006 622 632
40. E. Carboni, G.L. Tanda, R. Frau, and C.G. Di Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals J Neurochem 55 1990 1067 1070
41. S.R. Sesack, V.A. Hawrylak, C. Matus, M.A. Guido, and A.I. Levey Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter J Neurosci 18 1998 2697 2708 (Pubitemid 28141815)
42. J.W. Dalley, R.N. Cardinal, and T.W. Robbins Prefrontal executive and cognitive functions in rodents: Neural and neurochemical substrates Neurosci Biobehav Rev 28 2004 771 784 (Pubitemid 39535871)
43. W.E. Pratt, and S.J. Mizumori Neurons in rat medial prefrontal cortex show anticipatory rate changes to predictable differential rewards in a spatial memory task Behav Brain Res 123 2001 165 183 (Pubitemid 32496515)
44. A. Johnson, M.A. van der Meer, and A.D. Redish Integrating hippocampus and striatum in decision-making Curr Opin Neurobiol 17 2007 692 697
45. P. Voorn, L.J. Vanderschuren, H.J. Groenewegen, T.W. Robbins, and C.M. Pennartz Putting a spin on the dorsal-ventral divide of the striatum Trends Neurosci 27 2004 468 474 (Pubitemid 38951039)
46. P.L. Gabbott, T.A. Warner, P.R. Jays, P. Salway, and S.J. Busby Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers J Comp Neurol 492 2005 145 177 (Pubitemid 41443719)
47. N.D. Volkow, G.J. Wang, J.S. Fowler, J. Logan, D. Franceschi, and L. Maynard Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications Synapse 43 2002 181 187 (Pubitemid 34087672)
48. P.H. Kelly, P.W. Seviour, and S.D. Iversen Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum Brain Res 94 1975 507 522
49. G.D. Carr, and N.M. White Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study Psychopharmacology (Berl) 89 1986 340 346 (Pubitemid 16036191)
50. R.A. Wise, and M.A. Bozarth A psychomotor stimulant theory of addiction Psychol Rev 94 1987 469 492
51. A.E. Kelley, A.M. Gauthier, and C.G. Lang Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior Behav Brain Res 35 1989 27 39
52. C.W. Berridge Neural substrates of psychostimulant-induced arousal Neuropsychopharmacology 31 2006 2332 2340 (Pubitemid 44607049)
53. C.W. Berridge Noradrenergic modulation of arousal Brain Res Rev 58 2008 1 17
54. J. Biederman Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: Findings from a longitudinal follow-up of youths with and without ADHD J Clin Psychiatry 64 suppl 11 2003 3 8 (Pubitemid 37169642)
55. T.E. Wilens, S.V. Faraone, J. Biederman, and S. Gunawardene Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature Pediatrics 111 2003 179 185 (Pubitemid 36071051)
56. C.W. Berridge, and B.D. Waterhouse The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes Brain Res Brain Res Rev 42 2003 33 84 (Pubitemid 36369264)
57. E.C. Clayton, J. Rajkowski, J.D. Cohen, and G. Ston-Jones Phasic activation of monkey locus ceruleus neurons by simple decisions in a forced-choice task J Neurosci 24 2004 9914 9920 (Pubitemid 39463572)
58. A.F.T. Arnsten, and B.M. Li Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions Biol Psychiatry 57 2005 1377 1384 (Pubitemid 40798558)
59. C.W. Berridge The locus coeruleus-noradrenergic system and stress: Implications for post-traumatic stress disorder (PTSD) P.J. Shiromani, T.M. Keane, J.E. Ledoux, Posttraumatic Stress Disorder: Basic Science and Clinical Practice 2008 Humana/Springer New York
60. D.M. Devilbiss, and B.D. Waterhouse Effects of Tonic Versus Phasic Activation of the Locus Coeruleus on Thalamic and Cortical Neuronal Responsiveness to Afferent Pathway Stimulation 2002 Society for Neuroscience Washington, DC
61. L.M. Hurley, D.M. Devilbiss, and B.D. Waterhouse A matter of focus: Monoaminergic modulation of stimulus coding in mammalian sensory networks Curr Opin Neurobiol 14 2004 488 495 (Pubitemid 39089088)
62. D.K. Pitts, and J. Marwah Electrophysiological actions of cocaine on noradrenergic neurons in rat locus ceruleus J Pharmacol Exp Ther 240 1987 345 351 (Pubitemid 17235460)
63. A.L. Curtis, E. Conti, and R.J. Valentino Cocaine effects on brain noradrenergic neurons of anesthetized and unanesthetized rats Neuropharmacology 32 1993 419 428 (Pubitemid 23161550)
64. D.M. Devilbiss, and C.W. Berridge Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge J Pharmacol Exp Ther 319 2006 1327 1335
65. L.F. Agnati, D. Guidolin, M. Guescini, S. Genedani, and K. Fuxe Understanding wiring and volume transmission Brain Res Rev 64 2010 137 159
66. D.M. Devilbiss, and B.D. Waterhouse The effects of tonic locus coeruleus output on sensory-evoked responses of ventral posterior medial thalamic and barrel field cortical neurons in the awake rat J Neurosci 24 2004 10773 10785 (Pubitemid 39602389)
67. L.H. Miner, S. Schroeter, R.D. Blakely, and S.R. Sesack Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals J Comp Neurol 466 2003 478 494 (Pubitemid 37305993)
68. P. Eckhoff, K.F. Wong-Lin, and P. Holmes Optimality and robustness of a biophysical decision-making model under norepinephrine modulation J Neurosci 29 2009 4301 4311
69. G. Aston-Jones, and J.D. Cohen An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance Annu Rev Neurosci 28 2005 403 450 (Pubitemid 41098911)
70. S. Bouret, and S.J. Sara Network reset: A simplified overarching theory of locus coeruleus noradrenaline function Trends Neurosci 28 2005 574 582 (Pubitemid 41476687)
71. L. Clark, A.D. Blackwell, A.R. Aron, D.C. Turner, J. Dowson, T.W. Robbins, and B.J. Sahakian Association between response inhibition and working memory in adult ADHD: A link to right frontal cortex pathology? Biol Psychiatry 61 2007 1395 1401 (Pubitemid 46855766)
72. T. Lundqvist Imaging Cognitive Deficits in Drug Abuse vol 3 2009 Springer-Verlag Berlin
73. W.H. Green Nonstimulant drugs in the treatment of attention-deficit hyperactivity disorder Child Adolesc Psychiatr Clin N Am 1 1992 449 465
74. R.J. Baldessarini Antidepressant agents Chemotherapy in Psychiatry 1985 Harvard University Press Cambridge, MA
75. C. Bolden-Watson, and E. Richelson Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes Life Sci 52 1993 1023 1029
76. J. Biederman, R.J. Baldessarini, V. Wright, D. Knee, and J.S. Harmatz A double-blind placebo controlled study of desipramine in the treatment of ADD: I Efficacy J Am Acad Child Adolesc Psychiatry 28 1989 777 784 (Pubitemid 19239933)
77. D.R. Gastfriend, J. Biederman, and M.S. Jellinek Desipramine in the treatment of attention deficit disorder in adolescents Psychopharmacol Bull 21 1985 144 145 (Pubitemid 15010895)
78. J.L. Rapoport, A. Zametkin, M. Donnelly, and D. Ismond New drug trials in attention deficit disorder Psychopharmacol Bull 21 1985 232 236 (Pubitemid 15114524)
79. T. Spencer, J. Biederman, K. Kerman, R. Steingard, and T. Wilens Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette syndrome J Am Acad Child Adolesc Psychiatry 32 1993 354 360 (Pubitemid 23099642)
80. J.B. Prince, T.E. Wilens, J. Biederman, T.J. Spencer, R. Millstein, D.A. Polisner, and J.Q. Bostic A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder J Child Adolesc Psychopharmacol 10 2000 193 204
81. D.T. Wong, P.G. Threlkeld, K.L. Best, and F.P. Bymaster A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain J Pharmacol Exp Ther 222 1982 61 65 (Pubitemid 12096999)
82. D.R. Gastfriend, J. Biederman, and M.S. Jellinek Desipramine in the treatment of adolescents with attention deficit disorder Am J Psychiatry 141 1984 906 908 (Pubitemid 14079012)
83. T. Spencer, J. Biederman, T. Wilens, J. Prince, M. Hatch, and J. Jones Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder Am J Psychiatry 155 1998 693 695 (Pubitemid 28225414)
84. D. Michelson, L. Adler, T. Spencer, F.W. Reimherr, S.A. West, and A.J. Allen Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies Biol Psychiatry 53 2003 112 120 (Pubitemid 36126473)
85. R.L. Zerbe, H. Rowe, G.G. Enas, D. Wong, N. Farid, and L. Lemberger Clinical Pharmacology of tomoxetine, a potential antidepressant J Pharmacol Exp Ther 232 1985 139 143 (Pubitemid 15193663)
86. S.R. Chamberlain, C.N. Del, J. Dowson, U. Muller, L. Clark, T.W. Robbins, and B.J. Sahakian Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder Biol Psychiatry 62 2007 977 984 (Pubitemid 47562368)
87. E. Seu, A. Lang, R.J. Rivera, and J.D. Jentsch Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys Psychopharmacology (Berl) 202 2009 505 519
88. F.P. Bymaster, J.S. Katner, D.L. Nelson, S.K. Hemrick-Luecke, P.G. Threlkeld, and J.H. Heiligenstein Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 2002 699 711 (Pubitemid 35335888)
89. A.S. Horn Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates Br J Pharmacol 47 1973 332 338
90. M. Raiteri, C.R. del, A. Bertollini, and G. Levi Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine Eur J Pharmacol 41 1977 133 143 (Pubitemid 8015308)
91. A.F. Arnsten Stress impairs prefrontal cortical function in rats and monkeys: Role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms Prog Brain Res 126 2000 183 192 (Pubitemid 35461289)
92. E. MacDonald, B.K. Kobilka, and M. Scheinin Gene targetinghoming in on alpha 2-adrenoceptor-subtype function Trends Pharmacol Sci 18 1997 211 219 (Pubitemid 27283651)
93. R.D. Hunt, R.B. Minderaa, and D.J. Cohen Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial J Am Acad Child Psychiatry 24 1985 617 629 (Pubitemid 15249217)
94. R.D. Hunt, A.F.T. Arnsten, and M.D. Asbell An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder J Am Acad Child Adolesc Psychiatry 34 1995 50 54
95. L. Scahill, P.B. Chappell, Y.S. Kim, R.T. Schultz, L. Katsovich, and E. Shepherd A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder Am J Psychiatry 158 2001 1067 1074 (Pubitemid 32623110)
96. J. Biederman, R.D. Melmed, A. Patel, K. McBurnett, J. Konow, A. Lyne, and N. Scherer A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/ hyperactivity disorder Pediatrics 121 2008 e73 e84
97. P. Jakala, M. Riekkinen, J. Sirvio, E. Koivisto, K. Kejonen, M. Vanhanen, and P. Riekkinen Jr Guanfacine, but not clonidine, improves planning and working memory performance in humans Neuropsychopharmacology 20 1999 460 470 (Pubitemid 29123873)
98. J.S. Franowicz, and A.F. Arnsten The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys Psychopharmacology (Berl) 136 1998 8 14 (Pubitemid 28097515)
99. Z.M. Mao, A.F.T. Arnsten, and B.M. Li Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys Biol Psychiatry 46 1999 1259 1265 (Pubitemid 30114443)
100. J.C. Steere, and A.F. Arnsten The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys Behav Neurosci 111 1997 883 891 (Pubitemid 27469093)
101. R.A. Avery, J.S. Franowicz, C. Studholme, C.H. van Dyck, and A.F. Arnsten The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task Neuropsychopharmacology 23 2000 240 249 (Pubitemid 30609658)
102. C.W. Berridge, A.F.T. Arnsten, and S.L. Foote Noradrenergic modulation of cognitive function: Clinical implications of anatomical, electrophysiological and behavioural studies in animal models [editorial] Psychol Med 23 1993 557 564 (Pubitemid 23268073)
103. M. Wang, B.P. Ramos, C.D. Paspalas, Y. Shu, A. Simen, and A. Duque Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex Cell 129 2007 397 410 (Pubitemid 46574970)
104. A. Shenker The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: Focus on catecholamine receptor pharmacology Adv Pediatr 39 1992 337 382
105. P.H. Wender, D.R. Wood, F.W. Reimherr, and M. Ward An open trial of pargyline in the treatment of attention deficit disorder, residual type Psychiatry Res 9 1983 329 336 (Pubitemid 13002821)
106. A.J. Zametkin, and J.L. Rapoport Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 26 1987 676 686 (Pubitemid 18016148)
107. I.N. Mefford, and W.Z. Potter A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: A defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation Med Hypotheses 29 1989 33 42 (Pubitemid 19120427)
108. C.R. Yang, J.K. Seamans, and N. Gorelova Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex Neuropsychopharmacology 21 1999 161 194 (Pubitemid 29304579)
109. D.A. Lewis The catecholamine innervation of primate cerebral cortex M.V. Solanto, A.F.T. Arnsten, F.X. Castellanos, Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. 2001 Oxford University Press New York 77 103
110. C.D. Paspalas, and P.S. Goldman-Rakic Microdomains for dopamine volume neurotransmission in primate prefrontal cortex J Neurosci 24 2004 5292 5300 (Pubitemid 38747669)
111. H.H. Van Tol, J.R. Bunzow, H.C. Guan, R.K. Sunahara, P. Seeman, H.B. Niznik, and O. Civelli Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine Nature 350 1991 610 614 (Pubitemid 21912282)
112. A.F. Arnsten Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": A rational bridge between genetics and the symptoms of mental illness Cereb Cortex 17 suppl 1 2007 i6 i15
113. B.R. Postle Working memory as an emergent property of the mind and brain Neuroscience 139 2006 23 38
114. A.F.T. Arnsten, J.C. Steere, and R.D. Hunt The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function Potential significance for attention-deficit hyperactivity disorder Arch Gen Psychiatry 53 1996 448 455 (Pubitemid 26149234)
115. S. Birnbaum, K.T. Gobeske, J. Auerbach, J.R. Taylor, and A.F. Arnsten A role for norepinephrine in stress-induced cognitive deficits: Alpha-1-adrenoceptor mediation in the prefrontal cortex Biol Psychiatry 46 1999 1266 1274 (Pubitemid 30114444)
116. S.G. Birnbaum, P.X. Yuan, M. Wang, S. Vijayraghavan, A.K. Bloom, and D.J. Davis Protein kinase C overactivity impairs prefrontal cortical regulation of working memory Science 306 2004 882 884 (Pubitemid 39446999)
117. B.P. Ramos, L. Colgan, E. Nou, S. Ovadia, S.R. Wilson, and A.F. Arnsten The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys Biol Psychiatry 58 2005 894 900 (Pubitemid 41790718)
118. B.P. Ramos, L.A. Colgan, E. Nou, and A.F. Arnsten Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals Neurobiol Aging 29 2008 1060 1069 (Pubitemid 351711664)
119. S. Vijayraghavan, M. Wang, S.G. Birnbaum, G.V. Williams, and A.F. Arnsten Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory Nat Neurosci 10 2007 376 384
120. J.M. Fuster, and G.E. Alexander Neuron activity related to short-term memory Science 173 1971 652 654
121. S. Funahashi, C.J. Bruce, and P.S. Goldman-Rakic Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex J Neurophysiol 61 1989 331 349 (Pubitemid 19063448)
122. J.F. Smiley, S.M. Williams, K. Szigeti, and P.S. Goldman-Rakic Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex J Comp Neurol 321 1992 325 335
123. M.D. Lapiz, and D.A. Morilak Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability Neuroscience 137 2006 1039 1049 (Pubitemid 43053965)
124. Gamo NJ, Wang M, Arnsten AFT (in press): Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. J Amer Assoc Child Adoles Psychiatry.
125. B.G. Winsberg, J.A. Camp-Bruno, J. Vink, C.J. Timmer, and J. Sverd Mianserin pharmacokinetics and behavior in hyperkinetic children J Clin Psychopharmacol 7 1987 143 147 (Pubitemid 17111749)
126. A.J. Bobb, A.M. Addington, E. Sidransky, M.C. Gornick, J.P. Lerch, and D.K. Greenstein Support for association between ADHD and two candidate genes: NET1 and DRD1 Am J Med Genet B Neuropsychiatr Genet 134B 2005 67 72 (Pubitemid 40411112)
127. G. Daly, Z. Hawi, M. Fitzgerald, and M. Gill Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Mol Psychiatry 4 1999 192 196 (Pubitemid 29163984)
128. T. Roman, M. Schmitz, G.V. Polanczyk, M. Eizirik, L.A. Rohde, and M.H. Hutz Further evidence for the association between attention-deficit/ hyperactivity disorder and the dopamine-beta-hydroxylase gene Am J Med Genet 114 2002 154 158 (Pubitemid 34160466)
129. M.A. Bellgrove, Z. Hawi, M. Gill, and I.H. Robertson The cognitive genetics of attention deficit hyperactivity disorder (ADHD): Sustained attention as a candidate phenotype Cortex 42 2006 838 845 (Pubitemid 46768738)
130. C. Kieling, J.P. Genro, M.H. Hutz, and L.A. Rohde The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD Am J Med Genet B Neuropsychiatr Genet 147B 2008 485 490 (Pubitemid 351830808)
131. I.R. Gizer, C. Ficks, and I.D. Waldman Candidate gene studies of ADHD: A meta-analytic review Hum Genet 126 2009 51 90
132. J. Mill, A. Caspi, B.S. Williams, I. Craig, A. Taylor, and M. Polo-Tomas Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/ hyperactivity disorder: Evidence from 2 birth cohorts Arch Gen Psychiatry 63 2006 462 469